ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacrame...

FDA Recall #D-0086-2025 — Class I — November 4, 2024

Recall #D-0086-2025 Date: November 4, 2024 Classification: Class I Status: Ongoing

Product Description

ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zapmax.com

Reason for Recall

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Recalling Firm

Boulla LLC — Sacramento, CA

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

Unknown

Distribution

Nationwide within the United States

Code Information

Lot #: YZM240406, Exp: 04/05/2027

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated